Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

CONy 2024

The 18th Annual Congress on Controversies in Neurology
21–23 March 2024 | London, UK

CONy 2024

The 18th Annual Congress on Controversies in Neurology
21–23 March 2024 | London, UK
Treatment approaches in mild stroke cases 1:57
Treatment approaches in mild stroke cases
Robert Mikulik • 22 Mar 2024
Challenges in MS care: feedback gaps and cost-saving missteps 6:18
Challenges in MS care: feedback gaps and cost-saving missteps
Dominic Shadbolt et al. • 23 Mar 2024
Research needs in FCD: definitions and classifications 1:11
Research needs in FCD: definitions and classifications
Narinder Kapur • 22 Apr 2024
Should minimally invasive surgery be routinely discussed in ICH? 1:49
Should minimally invasive surgery be routinely discussed in ICH?
Robert Mikulik • 22 Mar 2024
AttackMS and ChariotMS: optimizing care from diagnosis to advanced disease 11:38
AttackMS and ChariotMS: optimizing care from diagnosis to advanced disease
Dominic Shadbolt et al. • 23 Mar 2024
Exploring the concept of cognitive reserve 1:31
Exploring the concept of cognitive reserve
Amos Korczyn • 28 Feb 2024
MRI findings are often missed in the diagnosis of prion diseases 2:33
MRI findings are often missed in the diagnosis of prion diseases
Michael Geschwind • 23 Mar 2024
Antisense oligonucleotides for C9orf72-associated ALS: explaining the lack of success 4:32
Antisense oligonucleotides for C9orf72-associated ALS: explaining the lack of success
Pamela Shaw • 1 May 2024
The role of TDP-43 in ALS pathology 2:28
The role of TDP-43 in ALS pathology
Pamela Shaw • 1 May 2024
Lessons in patience gained from the tofersen clinical trials 1:08
Lessons in patience gained from the tofersen clinical trials
Pamela Shaw • 1 May 2024
Progress in genetic therapies for ALS 10:28
Progress in genetic therapies for ALS
Pamela Shaw • 1 May 2024
UK perspective: cost-effectiveness of gene therapies for ALS 3:34
UK perspective: cost-effectiveness of gene therapies for ALS
Pamela Shaw • 1 May 2024
Discussing patient priorities for ALS research 1:31
Discussing patient priorities for ALS research
Pamela Shaw • 1 May 2024
The challenges and opportunities of using AI in medicine 3:33
The challenges and opportunities of using AI in medicine
Morris Levin • 22 Mar 2024
AssistMS: testing the value of an AI tool for MRI scan interpretation in clinical practice 14:45
AssistMS: testing the value of an AI tool for MRI scan interpretation in clinical practice
Dominic Shadbolt et al. • 23 Mar 2024
Challenging cases in medication overuse headache 1:01
Challenging cases in medication overuse headache
Morris Levin • 22 Mar 2024
The content of VJNeurology is intended for healthcare professionals